Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1

Status

Terminated 3Unknown 1Completed 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other 2Thoracic 1

Conditions

Neoplasms 2Constipation 2Pain 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 241Radiotherapy 217Gemcitabine 187Cisplatin 185Carboplatin 182Docetaxel 166Bevacizumab 166Paclitaxel 144Capecitabine 142Rituximab 141pembrolizumab 140Nivolumab 126Oxaliplatin 124Dexamethasone 122Fluorouracil 113fludarabine 104Radiosurgery 101Doxorubicin 99fludarabine phosphate 97Irinotecan 96Etoposide 95Lenalidomide 93Cytarabine 92Magnetic Resonance Spectroscopy 90Radiation 89Filgrastim 89Leucovorin 88Bortezomib 86Cetuximab 80Pemetrexed 79

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × OTHER × naloxegol × Clear all
NCT03087708 2025-07-17

Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer

Alliance for Clinical Trials in Oncology

Phase 2 Terminated
50 enrolled 24 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02745353 2019-12-09

Naloxegol in Cancer Opioid-Induced Constipation

University of California, San Diego

Phase 2 Terminated
7 enrolled 9 charts
Other

Constipation, Neoplasms

NCT02839889 2019-03-05

Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation)

Hospice of Henderson County, Inc.

Phase 4 Terminated
12 enrolled 33 charts
Other

Constipation, Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡